Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.

Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.
复制标题

DOI:
10.1155/2012/645969
复制
发表时间:
2012
期刊:
影响因子:
2.9
通讯作者:
Lee DL
Lee DL
中科院分区:
医学3区
文献类型:
--
作者:
Wilson JL;Duan R;El-Marakby A;Alhashim A;Lee DL

文献摘要

参考文献

被引文献

相似文献

PPAR-α 的抗炎特性在减轻高血压方面发挥着重要作用。目前的研究确定了 PPAR-α 激动剂在 Ang II 缓慢升压剂量(400ng/kg/min)期间的抗高血压和抗炎作用。将遥测装置植入 10 至 12 周龄的雄性 PPAR-α KO 小鼠及其 WT 对照小鼠中,并注射 Ang II 12 天。在 Ang II 输注第 12 天,与 WT 小鼠相比,PPAR-α KO 小鼠的 MAP 升高(161 ± 4mmHg 对比 145 ± 4mmHg),非诺贝特(145mg/kg/天)降低了 WT + Ang II 小鼠的 MAP(134 ± 7mmHg)。在 Ang II 输注第 12 天,PPAR-α KO 小鼠的血浆 IL-6 水平较高(30 ± 4 vs 8 ± 2 pg/mL),非诺贝特降低了 Ang II 处理的 WT 小鼠的血浆 IL-6(10 ± 3 pg/mL)。非诺贝特增加 WT + Ang II 小鼠肾 CYP4A 表达,恢复肾 CYP2J 表达,降低肾 ICAM-1、MCP-1 和 COX-2 升高。我们的结果表明,PPAR-α 的激活通过上调 CYP4A 和 CYP2J 以及减弱炎症标志物(如血浆 IL-6、肾 MCP-1、ICAM-1 和 COX-2 的肾表达)来减轻 Ang II 诱导的高血压。
The anti-inflammatory properties of PPAR-α plays an important role in attenuating hypertension. The current study determines the anti-hypertensive and anti-inflammatory role of PPAR-α agonist during a slow-pressor dose of Ang II (400 ng/kg/min). Ten to twelve week old male PPAR-α KO mice and their WT controls were implanted with telemetry devices and infused with Ang II for 12 days. On day 12 of Ang II infusion, MAP was elevated in PPAR-α KO mice compared to WT (161 ± 4 mmHg versus 145 ± 4 mmHg) and fenofibrate (145 mg/kg/day) reduced MAP in WT + Ang II mice (134 ± 7 mmHg). Plasma IL-6 levels were higher in PPAR-α KO mice on day 12 of Ang II infusion (30 ± 4 versus 8 ± 2 pg/mL) and fenofibrate reduced plasma IL-6 in Ang II-treated WT mice (10 ± 3 pg/mL). Fenofibrate increased renal expression of CYP4A, restored renal CYP2J expression, reduced the elevation in renal ICAM-1, MCP-1 and COX-2 in WT + Ang II mice. Our results demonstrate that activation of PPAR-α attenuates Ang II-induced hypertension through up-regulation of CYP4A and CYP2J and an attenuation of inflammatory markers such as plasma IL-6, renal MCP-1, renal expression of ICAM-1 and COX-2.
DOI: 10.1161/01.hyp.0000153317.06072.2e
发表时间: 2005-04-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Vera, T;Taylor, M;Stec, DE
通讯作者: Stec, DE
DOI: 10.1677/joe.0.1690453
发表时间: 2001-06-01
影响因子: 4
作者:
Delerive, P;Fruchart, JC;Staels, B
通讯作者: Staels, B
DOI: 10.1038/347645a0
发表时间: 1990-10-18
期刊: NATURE
影响因子: 64.8
作者:
ISSEMANN, I;GREEN, S
通讯作者: GREEN, S
DOI: 10.1161/01.hyp.0000172755.25382.fc
发表时间: 2005-08-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Williams, JM;Zhao, XY;Pollock, DM
通讯作者: Pollock, DM
DOI: 10.1161/01.hyp.34.1.118
发表时间: 1999-07-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Funakoshi, Y;Ichiki, T;Takeshita, A
通讯作者: Takeshita, A